A realist evaluation of the development of extended pharmacist roles and services in community pharmacies

• Published in: Research in social and administrative pharmacy 2024-03, Vol.20 (3), p.321-334
• Main Authors: Morris, Caroline, McDonald, Janet, Officer, Tara Nikki, Fa'asalele Tanuvasa, Ausaga, Smiler, Kirsten, Parore, Nora, Dunn, Phoebe, McKinlay, Eileen, Kennedy, Jonathan, McBride-Henry, Karen, Cumming, Jacqueline
• Format: Article
• Language: English
• Subjects: Community Pharmacy Services; Humans; New Zealand; Pharmacies; Pharmacists; Professional Role; Surveys and Questionnaires
• ISSN: 1551-7411; 1934-8150; 1934-8150
• DOI: 10.1016/j.sapharm.2023.11.006

Internationally, community pharmacy models of care have been moving away from a focus on dispensing to extended, clinically-focused roles for pharmacists. To identify how community pharmacy strategies were being implemented in Aotearoa New Zealand; how changes were expected to influence health and health system outcomes; what extended services were being delivered; the responses of pharmacists, other health professionals and consumers to these developments; and the contexts and mechanisms supporting the successful implementation of new community pharmacy services. A realist evaluation methodology was employed, to explore a complex policy intervention. Realist evaluation explores the contexts (C) within which initiatives are introduced and identifies the mechanisms (M) triggered by different contexts to produce outcomes (O). Realist evaluation processes iteratively develop, test, and refine CMO configurations. In this study, initial programme theories were developed through key government and professional policy documents, then refined through key informant interviews, a survey and interviews with pharmacists and intern (pre-registration) pharmacists, and finally, 10 case studies of diverse community pharmacies. Four intermediate health service outcomes were identified: development of extended community pharmacist services; consumers using extended community pharmacist services; more integrated, collaborative primary health care services; and a fit-for-purpose community pharmacy workforce. Enabling and constraining contexts are detailed for each outcome, along with the mechanisms that they trigger (or inhibit). There are wide-ranging and disparate levers to support the further development of extended community pharmacy services. These include aligning funding with desired services, undergraduate educators and professional leaders setting expectations for the pharmacists’ role in practice, and the availability of sufficient funding and time for both specific extended service accreditation and broader postgraduate training. However, no simple “fix” can be universally applied internationally, nor even in pharmacies within a single jurisdiction, to facilitate service development. •Worldwide, community pharmacists are moving to extended, clinically-focused roles.•Realist evaluation of extended community pharmacy services in Aotearoa/New Zealand.•Outcomes: services develop; used by consumers; integrated PHC; appropriate workforce.•Enabling and constraining contex